An adenoviral-vectored vaccine confers seroprotection against capsular group B meningococcal disease.
Dold C, Marsay L, Wang N, Silva-Reyes L, Clutterbuck E, Paterson GK, Sharkey K, Wyllie D, Beernink PT, Hill AV, Pollard AJ, Rollier CS.
Dold C, et al. Among authors: rollier cs.
Sci Transl Med. 2023 Jun 21;15(701):eade3901. doi: 10.1126/scitranslmed.ade3901. Epub 2023 Jun 21.
Sci Transl Med. 2023.
PMID: 37343082